Physician profile
Debra L Harvey
NPI 1003141623
$1,832.98
in general payments reported to CMS, 2019-2025
17 companies · $618 in 2025
The $618 reported for 2025 was more than what 94% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $50.92 · 2022: $244 · 2023: $341 · 2024: $579 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,537.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $528.27 | 2022-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $241.30 | 2023-2025 | Qelbree, Qelbree |
| Sanofi-Aventis U.S. LLC | $237.04 | 2023-2025 | |
| Collegium Pharmaceutical, INC. | $203.79 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $139.52 | 2022-2025 | Vaxneuvance, Gardasil 9, Proquad |
| Tris Pharma INC | $90.50 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $80.86 | 2024-2025 | Relexxii |
| Sanofi Pasteur INC. | $71.46 | 2021-2025 | |
| Corium, LLC | $47.37 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $38.44 | 2023-2024 | Flumist Quadrivalent |
| Hologic Sales and Service, LLC | $35.52 | 2023-2025 | Aptima |
| Cranial Technologies, INC | $32.58 | 2022-2023 | Doc Band |
| Abbott Laboratories | $23.27 | 2022 | |
| Glaxosmithkline, LLC. | $19.44 | 2022 | |
| Ironwood Pharmaceuticals, INC | $16.68 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.89 | 2023 | |
| Kaleo, INC. | $13.05 | 2023 | Auvi-Q |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Harvey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.